DiaMedica Therapeutics Inc logo

DMAC

NASDAQ

DiaMedica Therapeutics Inc

Price unavailable — configure POLYGON_API_KEY

Key Statistics
Market Cap$363.84M
P/E RatioN/A
Div. Yield
EPS (TTM)-$0.69
52W High$10.42
52W Low$3.19
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees35
Price Performance
1 Week-4.57%
3 Month-24.12%
1 Year+76.09%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$54.16M
Liabilities$3.10M
Net Income$19.38M loss

About

DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company is headquartered in Minneapolis, Minnesota.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze DMAC with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.